The role of alliance in modern biotech industries in developing countries

Current Science

Volumn 87, Issue 7, 2004, Pages 874-884

  Ghosh, Prasanta K ^a  

^a NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 7644240215     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Ghosh, P. K., 'Prospects for biotechnology in India'. In Business Opportunities in Biotechnology, (ed. Tewari, S.), Confederation of Indian Industry, New Delhi, 2001, pp. 1-18.
2. Ghosh, P. K., 'Indian experience in commercializing institutionally developed biotechnologies'. J. Sci. Ind. Res., 1996, 55, 860-872.
3. Cartegana Protocol on Biosafety of the Convention on Biological Diversity, United Nations Environmental Programme, United Nations Industrial Development Organization, Montreal, Canada, adopted on 29 January 2000; http://www.biodiv.org/biosafety/
4. Wilmut, I., Schnieke, A. E., Mc Whir, J., Kind, A. J. and Campbell, K. H. S., Viable offspring derived from fetal and adult mammalian cells. Nature, 1997, 385, 810-813.
5. Campbell, K. H. S., Mc Whir, J., Richie, W. A. and Wilmut, I., Sheep cloned by nuclear transfer from a cultural cell line. Nature, 1996, 380, 64-66.
6. Ghosh, P. K., Growth and development of biotechnology during the last five decades and its future prospects. In the Fifth Golden Jubilee Commemoration Lecture of the Eastern India Section of the Royal Society of Chemistry, University of North Bengal, West Bengal, 23 September 2003.
7. Convention on Biological Diversity: Text and Annexure, signed by countries at the time of the United Nations Conference on Environment and Development, Rio de Janerio, Brazil, 3-14 June 1992. Secretariat of the Convention on Biological Diversity at Montreal, Quebec, Canada; http://www.biodiv.org
8. Ghosh, P. K., IPR issues in biotechnology inventions in developing countries in WTO era, 2003; http://www.patentmatics.com/pub2003/pub1d.html
9. Powell, W. W., Inter-organizational collaboration in biotechnology industry. J. Inst. Theor. Econ., 1996, 152, 197-212.
10. Powell, W. W., Learning from collaborations, knowledge and networks in the BT and pharmaceutical industries. Calif. Manage. Rev., 1998, 40, 228-240.
11. Sandhya, G. D. and Visalakshi, S., R&D capability and alliances in the pharmaceutical industry in India. Sci. Public Policy, 2000, 27, 109-121.
12. Fransman, M., Designing Dolly: interactions between economics, technology and science and the evolution of hybrid institutions. Res. Policy, 2001, 30, 263-273.